SCHEMBL30041533

SCHEMBL30041533

Clc1cccc(-c2cnc(Cl)o2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCP P55072 1/20 0.55
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
RAB9A P51151 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SOS1 Q07889 1/20 0.45
FFAR1 O14842 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
GABRP O00591 2/20 0.44
GABRD O14764 2/20 0.44
GABRA1 P14867 2/20 0.44
GABRB1 P18505 2/20 0.44
GABRG2 P18507 2/20 0.44
GABRB3 P28472 2/20 0.44
GABRA5 P31644 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23539672 1.00 VCP (0.55) VCPNPC1TP53TSHRNFKB1
SCHEMBL17129773 0.82 MAP4K4 (0.51) NPC1RAB9A
SCHEMBL26307287 0.82 FLT1 (0.49) VCPNPC1TP53TSHRRAB9A
SCHEMBL5186343 0.82 HSD17B1 (0.58) VCPTP53SMN1; SMN2GABRPGABRD
SCHEMBL9954595 0.82 GABRP (0.46) VCPFFAR1GABRPGABRDGABRA1
SCHEMBL1544316 0.82 VCP (0.52) VCPNPC1TP53TSHRNFKB1
SCHEMBL31557485 0.82 VCP (0.52) VCPNPC1TP53TSHRNFKB1
SCHEMBL20243152 0.82 VCP (0.52) VCPNPC1TP53TSHRNFKB1
SCHEMBL29231690 0.81 TSHR (0.66) VCPNPC1TP53TSHRNFKB1
SCHEMBL1363021 0.80 ALOX15 (0.59) VCPNPC1TP53TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115279741-A 4-phenyl-N- (phenyl) thiazol-2-amine derivatives and related compounds as Aryl Hydrocarbon Receptor (AHR) agonists for the treatment of, for example, angiogenesis-related disorders or inflammatory disorders 医肯纳肿瘤学公司 2022-11-01 CN disclosed